Data from the PERSEUS trial support the FDA approval of the subcutaneous daratumumab-containing regimen in newly diagnosed multiple myeloma. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results